First Light Asset Management, LLC
First Light Asset Management, LLC reported 31 holdings worth US$1.65B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
First Light Asset Management, LLC reported 31 holdings worth US$1.65B as of Jun 30, 2026. Largest: Neogenomics, Inc., Si-bone, Inc. and Axogen, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 31
- Value as reported
- US$1.65B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Neogenomics, Inc. | 12.3M | US$179M | 10.9% |
| Si-bone, Inc. | 8.13M | US$133M | 8.1% |
| Axogen, Inc. | 2.75M | US$127M | 7.7% |
| Apogee Therapeutics, Inc. | 930K | US$123M | 7.5% |
| Palvella Therapeutics, Inc. | 772K | US$118M | 7.2% |
| Twist Bioscience Corporation | 728K | US$74.9M | 4.6% |
| Enliven Therapeutics, Inc. | 1.36M | US$69.1M | 4.2% |
| Guardant Health, Inc. | 442K | US$66.3M | 4.0% |
| 908 Devices Inc. | 6.28M | US$54.7M | 3.3% |
| Amylyx Pharmaceuticals, Inc. | 3.02M | US$54.3M | 3.3% |
| Genedx Holdings Corp. | 784K | US$53.8M | 3.3% |
| Simulations Plus, Inc. | 2.79M | US$51.1M | 3.1% |
| Tandem Diabetes Care, Inc. | 3.38M | US$51.1M | 3.1% |
| Crinetics Pharmaceuticals, Inc. | 1.36M | US$50.9M | 3.1% |
| Neuropace, Inc. | 2.86M | US$45.5M | 2.8% |
| Edgewise Therapeutics, Inc. | 1.1M | US$44.5M | 2.7% |
| Anaptysbio, Inc. | 582K | US$39.3M | 2.4% |
| Trevi Therapeutics, Inc. | 2.1M | US$39.1M | 2.4% |
| Septerna, Inc. | 963K | US$32.3M | 2.0% |
| Trisalus Life Sciences, Inc. | 6.55M | US$29.8M | 1.8% |
| Tectonic Therapeutic, Inc. | 801K | US$27.5M | 1.7% |
| Health Catalyst, Inc | 12.8M | US$25.5M | 1.5% |
| Butterfly Network, Inc. | 2.64M | US$22.2M | 1.4% |
| Establishment Labs Holdings Inc. | 247K | US$21.2M | 1.3% |
| Vaxcyte, Inc. | 345K | US$20.1M | 1.2% |
| Irhythm Holdings, Inc. | 167K | US$19.9M | 1.2% |
| Omnicell, Inc. | 452K | US$18.8M | 1.1% |
| Atricure, Inc. | 568K | US$15.9M | 0.97% |
| Koru Medical Systems, Inc. | 3.39M | US$14.2M | 0.86% |
| Tactile Systems Technology, Inc. | 463K | US$13.8M | 0.84% |
| Rhythm Pharmaceuticals, Inc. | 85,765 | US$9.52M | 0.58% |
| Mimedx Group, Inc | 0 | US$0 | 0.00% |
| Organogenesis Holdings Inc. | 0 | US$0 | 0.00% |
| Spyglass Pharma, Inc. | 0 | US$0 | 0.00% |
| Vera Therapeutics, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related